{"altmetric_id":2567556,"counts":{"readers":{"mendeley":39,"citeulike":0,"connotea":0},"policy":{"unique_users_count":2,"unique_users":["msf_int","who"],"posts_count":3},"total":{"posts_count":3}},"citation":{"altmetric_jid":"4f6fa4ee3cf058f610002c37","authors":["Helen Bygrave","Nathan Ford","Gilles van Cutsem","Katherine Hilderbrand","Guillaume Jouquet","Eric Goemaere","Nathalie Vlahakis","Laura Trivi\u00f1o","Lipontso Makakole","Katharina Kranzer"],"doi":"10.1097\/qai.0b013e3182097505","endpage":"e78","first_seen_on":"2014-08-03T20:33:46+00:00","handles":[],"isbns":[],"issns":["1525-4135"],"issue":"3","journal":"JAIDS: Journal of Acquired Immune Deficiency Syndromes","last_mentioned_on":1305072000,"links":["http:\/\/dx.doi.org\/10.1097\/QAI.0b013e3182097505"],"pmid":"21164354","pubdate":"2011-03-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"e75","subjects":["acquiredimmunodeficiencysyndrome"],"title":"Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years.","type":"article","volume":"56","mendeley_url":"http:\/\/www.mendeley.com\/research\/implementing-tenofovirbased-firstline-regimen-rural-lesotho-clinical-outcomes-toxicities-after-two-y"},"altmetric_score":{"score":6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6},"context_for_score":{"all":{"total_number_of_other_articles":8399037,"mean":7.0727657654921,"rank":1397851,"this_scored_higher_than_pct":82,"this_scored_higher_than":6923704,"rank_type":"exact","sample_size":8399037,"percentile":82},"similar_age_3m":{"total_number_of_other_articles":182490,"mean":7.7945800020826,"rank":32759,"this_scored_higher_than_pct":81,"this_scored_higher_than":149538,"rank_type":"exact","sample_size":182490,"percentile":81},"this_journal":{"total_number_of_other_articles":2495,"mean":4.0807690457097,"rank":320,"this_scored_higher_than_pct":83,"this_scored_higher_than":2089,"rank_type":"exact","sample_size":2495,"percentile":83},"similar_age_this_journal_3m":{"total_number_of_other_articles":84,"mean":5.2947710843373,"rank":17,"this_scored_higher_than_pct":79,"this_scored_higher_than":67,"rank_type":"exact","sample_size":84,"percentile":79}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":5,"Researcher":7,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":7,"Student  > Postgraduate":3,"Student  > Master":8,"Other":4,"Lecturer":1,"Lecturer > Senior Lecturer":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":26,"Chemistry":1,"Psychology":2,"Agricultural and Biological Sciences":5,"Business, Management and Accounting":3,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"NE":1,"US":2,"ZA":1,"CH":1,"ET":1}}},"posts":{"policy":[{"title":"MSF Report: Fragile progress as several countries upgrade to better AIDS treatment","url":"http:\/\/www.msf.org\/sites\/msf.org\/files\/old-cms\/fms\/article-documents\/Getting_Ahead_of_the_Wave_May_20111.pdf","license":"public","citation_ids":[15385998,2365862,2567548,2567551,20534457,2567417,235291,15795026,524616,2567555,2567550,16016411,2567556,16016412,16016415,2567557,2567553,130319,2567554,440526,1967830,16016417,16016520],"posted_on":"2011-05-11T00:00:00+00:00","source":{"name":"MSF International","description":"M\u00e9decins Sans Fronti\u00e8res (MSF), also known as Doctors Without Borders, is an international medical humanitarian non-governmental organization which works in war-torn regions and developing countries facing endemic diseases.","geo":{"country":"CH"}},"page_url":"http:\/\/www.msf.org\/en\/article\/msf-report-fragile-progress-several-countries-upgrade-better-aids-treatment","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-1bee4c0a3bce9a00aca350645994486db62be842e29fb342e2be72546bd35a1f.jpg"}},{"title":"The treatment 2.0 framework for action:  catalysing the next phase of treatment, care and support","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44640\/1\/9789241501934_eng.pdf","license":"public","citation_ids":[20571740,22397302,1100649,4401340,2567417,537494,15371570,113243,4707776,1360495,1558812,100347,2567553,2567556,440526,235415,2461318,239819,15053675],"posted_on":"2011-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44640","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-01d7d57e580c4c6c419b40b66ddd397f922365582fffe11878b74b3c38887bd2.jpg"}},{"title":"Marco de accio\u0301n del tratamiento 2.0 : impulsionando la pro\u0301xima generacio\u0301n del tratamiento, la atencio\u0301n y el apoyo","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44702\/1\/9789243501932_spa.pdf","license":"public","citation_ids":[20571740,22397302,1100649,4401340,2567417,537494,15371570,113243,4707776,1360495,1558812,100347,2567553,2567556,440526,235415,2461318,239819,15053675],"posted_on":"2011-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/44702","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-a8943397e6ee9525085cee7f4318f8ea5215fdab5f63bfcf5a35f76b6724372e.jpg"}}]}}